Cargando…
Therapeutic options in peripheral T cell lymphoma
Peripheral T cell lymphoma (PTCL) is a rare and heterogeneous group of non-Hodgkin lymphomas with a very poor prognosis. The standard first-line treatments have resulted in unsatisfactory patient outcomes. With the exception of low-risk anaplastic lymphoma kinase (ALK)-positive anaplastic large cell...
Autores principales: | Zhang, Yaping, Xu, Wei, Liu, Hong, Li, Jianyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830033/ https://www.ncbi.nlm.nih.gov/pubmed/27071634 http://dx.doi.org/10.1186/s13045-016-0267-0 |
Ejemplares similares
-
An update on the management of peripheral T-cell lymphoma and emerging treatment options
por: Phillips, Adrienne A, et al.
Publicado: (2011) -
Peripheral T-Cell Lymphomas: Therapeutic Approaches
por: Sibon, David
Publicado: (2022) -
Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma
por: Stuver, Robert, et al.
Publicado: (2023) -
Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy
por: Wang, Xiaotong, et al.
Publicado: (2018) -
Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas
por: Orlova, Anna, et al.
Publicado: (2017)